دورية أكاديمية

Colonic PDGFRα Overexpression Accompanied Forkhead Transcription Factor FOXO3 Up-Regulation in STZ-Induced Diabetic Mice.

التفاصيل البيبلوغرافية
العنوان: Colonic PDGFRα Overexpression Accompanied Forkhead Transcription Factor FOXO3 Up-Regulation in STZ-Induced Diabetic Mice.
المؤلفون: Hongli Lu, Chunmei Zhang, Nina Song, Chen Lu, Ling Tong, Xu Huang, Young-chul Kim, Jie Chen, Wenxie Xu
المصدر: Annals of Nutrition & Metabolism; Oct2017, p158-171, 14p
مصطلحات موضوعية: PROTEIN metabolism, CELL proliferation, ANIMAL experimentation, BIOLOGICAL assay, CELL receptors, CELLULAR signal transduction, COLON (Anatomy), DIABETES, GASTROINTESTINAL motility, GLUCOSE, IMMUNOHISTOCHEMISTRY, MICE, PHOSPHORYLATION, PLATELET-derived growth factor, POLYMERASE chain reaction, SMOOTH muscle, TRANSCRIPTION factors, WESTERN immunoblotting, STATISTICAL significance, REVERSE transcriptase polymerase chain reaction, IN vivo studies
مستخلص: Background: Colonic transit disorder-induced constipation is a major complication in diabetic patients. PDGFRα+ (platelet-derived growth factor receptor α-positive) cells play critical roles in the inhibitory regulation of colonic motility and FOXO3 (forkhead transcription factor 3) has a broad range of biological functions. The present study was designed to investigate the relationship between FOXO3 and PDGFRα+ cell proliferation in streptozotocin (STZ)- induced diabetic mice. Methods: The major experimental techniques used in this paper are immunohistochemistry, quantitative RT-RCR and Western blotting for the evaluation of specific protein expression; ChIP assay for identifying the interaction between FOXO3 protein and the PDGFRα promotor; and lentiviral transfection for the overexpression of short hairpin RNAs (shRNAs) to down-regulate FOXO3. Results: In proximal colonic smooth muscle tissue of STZinduced diabetic mice, there was a significant increase in PDGFRα and Ki67 immunoreactivity. PDGFRa mRNA and protein expression levels were both significantly increased in colonic smooth muscle tissue, but PDGFRb expression was unchanged. Meanwhile, the expression of PDGF ligands, including both PDGFα and PDGFβ, was significantly increased in diabetic colonic smooth muscle tissue. In whole cell and nuclear extracts, the expression of FOXO3 protein was also significantly increased; however, the expression of P-FOXO3 (phosphorylated FOXO3) protein was significantly decreased. When NIH cells were incubated with 50 mmol/L glucose for 12 h, 24 h and 48 h, the expression of PDGFRa significantly increased, and in whole cell and nuclear extracts, the expression of FOXO3 protein was significantly increased. However, the expression of P-FOXO3 protein was significantly decreased. FOXO3 could bind to a site on the PDGFRα promoter, and the basal expression of PDGFRa was significantly reduced when endogenous FOXO3 expression was knocked down with FOXO3 short hairpin RNA (shRNA) in NIH cells. The expression of phosphorylated Akt was significantly down-regulated in diabetic colonic muscle tissue. Conclusions: These results suggest that diabetes-induced colonic PDGFRα+ cell proliferation is mediated by FOXO3 up-regulation. FOXO3 up-regulation may be induced by inhibiting the PI3K/Akt signaling pathway in STZ-induced diabetic mice. PDGFRα+ cell proliferation could be a new target for clinical therapy of diabetes-induced colonic transit disorder. [ABSTRACT FROM AUTHOR]
Copyright of Annals of Nutrition & Metabolism is the property of Karger AG and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
قاعدة البيانات: Complementary Index
الوصف
تدمد:02506807
DOI:10.1159/000480335